AU2001268064A1 - Derivatives of 2,3,6,7,12,12a-hexahydropyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione - Google Patents
Derivatives of 2,3,6,7,12,12a-hexahydropyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dioneInfo
- Publication number
- AU2001268064A1 AU2001268064A1 AU2001268064A AU6806401A AU2001268064A1 AU 2001268064 A1 AU2001268064 A1 AU 2001268064A1 AU 2001268064 A AU2001268064 A AU 2001268064A AU 6806401 A AU6806401 A AU 6806401A AU 2001268064 A1 AU2001268064 A1 AU 2001268064A1
- Authority
- AU
- Australia
- Prior art keywords
- hexahydropyrazino
- pyrido
- dione
- indole
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21013700P | 2000-06-07 | 2000-06-07 | |
US60/210,137 | 2000-06-07 | ||
US60210137 | 2000-06-07 | ||
PCT/US2001/015936 WO2001094345A2 (en) | 2000-06-07 | 2001-05-15 | Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001268064A1 true AU2001268064A1 (en) | 2001-12-17 |
Family
ID=22781718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001268064A Abandoned AU2001268064A1 (en) | 2000-06-07 | 2001-05-15 | Derivatives of 2,3,6,7,12,12a-hexahydropyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione |
Country Status (7)
Country | Link |
---|---|
US (1) | US6872721B2 (en) |
EP (1) | EP1289989A2 (en) |
JP (1) | JP2004501124A (en) |
AU (1) | AU2001268064A1 (en) |
CA (1) | CA2411008C (en) |
MX (1) | MXPA02012076A (en) |
WO (1) | WO2001094345A2 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0020588D0 (en) * | 2000-08-21 | 2000-10-11 | Pfizer Ltd | Treatment of wounds |
CA2441792C (en) * | 2001-04-25 | 2010-08-03 | Lilly Icos Llc | Carboline derivatives as inhibitors of phosphodiesterase 5 (pdes) for the treatment of cardiovascular diseases and erectile dysfunction |
ES2341240T3 (en) | 2002-12-13 | 2010-06-17 | Warner-Lambert Company Llc | BINDING ALFA-2-DELTA TO TREAT SYMPTOMS OF LOWER URINARY TRACT. |
WO2005016244A2 (en) * | 2003-06-13 | 2005-02-24 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
US7449462B2 (en) | 2004-01-22 | 2008-11-11 | Pfizer, Inc. | Triazole derivatives which inhibit vasopressin antagonistic activity |
CA2577442A1 (en) | 2004-08-17 | 2006-03-02 | The Johns Hopkins University | Pde5 inhibitor compositions and methods for treating cardiac indications |
CA2687614C (en) * | 2007-06-07 | 2013-04-30 | Joyant Pharmaceuticals, Inc. | Methods for preparing diazonamides |
JP5501251B2 (en) | 2008-01-11 | 2014-05-21 | アルバニー モレキュラー リサーチ, インコーポレイテッド | (1-Azinone) substituted pyridoindoles as MCH antagonists |
AU2009243056B2 (en) * | 2008-04-29 | 2015-05-14 | Joyant Pharmaceuticals, Inc. | Indoline anti-cancer agents |
WO2009143485A1 (en) * | 2008-05-22 | 2009-11-26 | Joyant Pharmaceuticals, Inc. | Diazonamide analogs |
WO2011003007A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
WO2011003012A1 (en) * | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof |
JP2012532144A (en) | 2009-07-01 | 2012-12-13 | アルバニー モレキュラー リサーチ, インコーポレイテッド | Azinone-substituted azepino [B] indoles and pyrido-pyrrolo-azepine MCH-1 antagonists and methods for making and using the same |
US9073925B2 (en) | 2009-07-01 | 2015-07-07 | Albany Molecular Research, Inc. | Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
WO2012088038A2 (en) | 2010-12-21 | 2012-06-28 | Albany Molecular Research, Inc. | Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof |
WO2012088124A2 (en) | 2010-12-21 | 2012-06-28 | Albany Molecular Research, Inc. | Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof |
LT2699580T (en) | 2011-04-22 | 2018-01-10 | Joyant Pharmaceuticals, Inc. | Diazonamide analogs |
ES2700989T3 (en) | 2012-12-21 | 2019-02-20 | Mayo Found Medical Education & Res | Methods and materials to treat calcified aortic valve stenosis |
CN103554005A (en) * | 2013-11-22 | 2014-02-05 | 长沙理工大学 | Novel simple synthesis method of L-5-hydroxytryptophan |
AU2019229256A1 (en) | 2018-02-28 | 2020-09-17 | Ferro Therapeutics, Inc. | Compounds with ferroptosis inducing activity and methods of their use |
US11040964B2 (en) | 2019-02-27 | 2021-06-22 | Ferro Therapeutics, Inc. | Compounds and methods of use |
CN110498796B (en) * | 2019-05-15 | 2022-01-18 | 兰州大学 | Tadalafil analogue containing sulfonyl fluoride group and synthesis method thereof |
CN111303001B (en) * | 2020-04-10 | 2022-12-20 | 苏州爱玛特生物科技有限公司 | Synthesis method of indole mono-substituted 2-hydroxy-3- (1H-indol-3-yl) propionic acid compound |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9401090D0 (en) * | 1994-01-21 | 1994-03-16 | Glaxo Lab Sa | Chemical compounds |
GB9514464D0 (en) * | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Medicaments |
-
2001
- 2001-05-15 WO PCT/US2001/015936 patent/WO2001094345A2/en active Application Filing
- 2001-05-15 US US10/297,245 patent/US6872721B2/en not_active Expired - Fee Related
- 2001-05-15 MX MXPA02012076A patent/MXPA02012076A/en active IP Right Grant
- 2001-05-15 CA CA002411008A patent/CA2411008C/en not_active Expired - Fee Related
- 2001-05-15 EP EP01945960A patent/EP1289989A2/en not_active Withdrawn
- 2001-05-15 JP JP2002501894A patent/JP2004501124A/en active Pending
- 2001-05-15 AU AU2001268064A patent/AU2001268064A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6872721B2 (en) | 2005-03-29 |
JP2004501124A (en) | 2004-01-15 |
WO2001094345A2 (en) | 2001-12-13 |
MXPA02012076A (en) | 2003-06-06 |
CA2411008A1 (en) | 2001-12-13 |
US20030225092A1 (en) | 2003-12-04 |
EP1289989A2 (en) | 2003-03-12 |
CA2411008C (en) | 2006-04-11 |
WO2001094345A3 (en) | 2002-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001268064A1 (en) | Derivatives of 2,3,6,7,12,12a-hexahydropyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione | |
AU2002214505A1 (en) | New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives | |
AU2002221827A1 (en) | Novel lactame-substituted pyrazolopyridine derivatives | |
AU2002216028A1 (en) | Novel carbamate-substituted pyrazolopyridine derivatives | |
AU2001295992A1 (en) | Imidazopyridine derivatives | |
AU2001291893A1 (en) | Use of substituted imidazo(1,2-a)pyridine-, imidazo(1,2-a)pyrimidine and imidazo(1,2-a)pyrazine-3-yl-amine derivatives for producing NOS-inhibiting medicaments | |
AU2002361992A1 (en) | 1,4-dihydro-1,4-diphenylpyridine derivatives | |
AU3464599A (en) | Aminoalkyl substituted 9h-pyridino(2,3-b)indole and 9h-pyrimidino(4,5-b)indole derivatives | |
AU2002227919A1 (en) | Novel sulfonamide-substituted pyrazolopyridine derivatives | |
AU4808300A (en) | 9h-pyrimido(4,5-b)indole derivatives: crf1 specific ligands | |
AU3546601A (en) | Pyrimidine-4-one derivatives as LDL-PLA<sub>2</sub> inhibitors | |
AU2002352142A1 (en) | Pyrazolopyridine derivatives | |
AU2002361407A1 (en) | Triazolo(4,3-a)pyrido(2,3-d)pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof | |
AU4207197A (en) | 3-substituted pyrido(4',3':4,5)thieno(2,3-d)pyrimidine derivatives, their preparation and their use | |
PL349364A1 (en) | Use of pyridazino[4,5-b | |
AU3041700A (en) | Imidazo(4,5-c)-pyridine-4-on-derivatives | |
AU5065999A (en) | Naphthyridine derivatives | |
AU4364400A (en) | Azaindole derivatives for the treatment of depression | |
AU2003211993A1 (en) | (1,2,4)TRIAZOLO(1,5-c)PYRIMIDINE DERIVATIVES | |
AU2001269781A1 (en) | Substituted 2,3,7,8,9,10,11,12-octahydroazepino(4,5-b)pyrano(3,2-e) indoles | |
AU5919900A (en) | Cyclized amino acid derivatives | |
AU6831500A (en) | 1h-pirido[3, 4-b]indol-1-one derivatives | |
CA2412594A1 (en) | Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives | |
AU5368699A (en) | Derivatives of triptolide, and preparation and uses thereof | |
AU2002359160A1 (en) | PIPAZOLO (1,5-a) PYRIMIDINE DERIVATIVES AS MODULATORS OF PPAR |